Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4642464
Max Phase: Preclinical
Molecular Formula: C45H60BrN8O11+
Molecular Weight: 968.92
Molecule Type: Unknown
Associated Items:
ID: ALA4642464
Max Phase: Preclinical
Molecular Formula: C45H60BrN8O11+
Molecular Weight: 968.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccc(Br)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCC[N+](C)(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(N)=O
Standard InChI: InChI=1S/C45H59BrN8O11/c1-27(48-43(63)35(24-28-10-6-5-7-11-28)52-41(61)30-15-17-31(46)18-16-30)40(60)51-36(25-29-13-19-32(56)20-14-29)44(64)50-34(12-8-9-23-54(2,3)4)42(62)53-37(26-55)45(65)49-33(39(47)59)21-22-38(57)58/h5-7,10-11,13-20,27,33-37,55H,8-9,12,21-26H2,1-4H3,(H9-,47,48,49,50,51,52,53,56,57,58,59,60,61,62,63,64,65)/p+1/t27-,33-,34-,35-,36-,37-/m0/s1
Standard InChI Key: YWACDKZPYSQVFM-QJSKOQLASA-O
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 968.92 | Molecular Weight (Monoisotopic): 967.3559 | AlogP: 0.40 | #Rotatable Bonds: 26 |
Polar Surface Area: 295.45 | Molecular Species: ACID | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.95 | CX Basic pKa: | CX LogP: -3.50 | CX LogD: -2.73 |
Aromatic Rings: 3 | Heavy Atoms: 65 | QED Weighted: 0.04 | Np Likeness Score: 0.11 |
1. Milosevich N, McFarlane J, Gignac MC, Li J, Brown TM, Wilson CR, Devorkin L, Croft CS, Hof R, Paci I, Lum JJ, Hof F.. (2020) Pan-specific and partially selective dye-labeled peptidic inhibitors of the polycomb paralog proteins., 28 (1): [PMID:31753799] [10.1016/j.bmc.2019.115176] |
Source(1):